Myriad Genetics Inc (MYGN)
17.60
-0.24
(-1.32%)
USD |
NASDAQ |
Nov 05, 16:00
17.50
-0.10
(-0.54%)
After-Hours: 18:45
Myriad Genetics Gross Profit Margin (Quarterly): 69.55% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 69.55% |
| March 31, 2024 | 68.05% |
| December 31, 2023 | 68.67% |
| September 30, 2023 | 69.98% |
| June 30, 2023 | 68.50% |
| March 31, 2023 | 67.33% |
| December 31, 2022 | 69.68% |
| September 30, 2022 | 67.77% |
| June 30, 2022 | 72.28% |
| March 31, 2022 | 70.89% |
| December 31, 2021 | 71.52% |
| September 30, 2021 | 71.43% |
| June 30, 2021 | 71.65% |
| March 31, 2021 | 70.94% |
| September 30, 2020 | 69.56% |
| June 30, 2020 | 60.62% |
| March 31, 2020 | 69.45% |
| December 31, 2019 | 74.58% |
| September 30, 2019 | 73.32% |
| June 30, 2019 | 76.51% |
| March 31, 2019 | 77.56% |
| December 31, 2018 | 75.97% |
| September 30, 2018 | 75.43% |
| June 30, 2018 | 76.38% |
| March 31, 2018 | 75.91% |
| Date | Value |
|---|---|
| December 31, 2017 | 76.37% |
| September 30, 2017 | 75.95% |
| June 30, 2017 | 73.00% |
| March 31, 2017 | 77.50% |
| December 31, 2016 | 77.40% |
| September 30, 2016 | 77.46% |
| June 30, 2016 | 76.89% |
| March 31, 2016 | 78.90% |
| December 31, 2015 | 79.00% |
| September 30, 2015 | 80.11% |
| June 30, 2015 | 79.78% |
| March 31, 2015 | 79.83% |
| December 31, 2014 | 79.45% |
| September 30, 2014 | 79.32% |
| June 30, 2014 | 83.59% |
| March 31, 2014 | 85.45% |
| December 31, 2013 | 87.19% |
| September 30, 2013 | 87.41% |
| June 30, 2013 | 87.28% |
| March 31, 2013 | 87.00% |
| December 31, 2012 | 86.67% |
| September 30, 2012 | 87.01% |
| June 30, 2012 | 87.25% |
| March 31, 2012 | 86.72% |
| December 31, 2011 | 86.88% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
60.62%
Minimum
Jun 2020
74.58%
Maximum
Dec 2019
69.58%
Average
69.62%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.83% |
| Abbott Laboratories | 55.83% |
| Personalis Inc | 35.59% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 76.19% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.96% |
| Return on Assets | -13.67% |
| Return on Invested Capital | -19.92% |
| Profit Margin (Quarterly) | -17.35% |
| Operating Margin (Quarterly) | -11.77% |
| Return on Net Operating Assets | -14.35% |